CompletedPhase 2NCT04424147
Efficacy and Safety of HVA Regimens as Salvage Treatment in rrAML
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Nanfang Hospital, Southern Medical University
- Principal Investigator
- Qifa LiuNanfang Hospital, Southern Medical University
- Intervention
- HVA Regimens as Salvage Treatment(combination_product)
- Enrollment
- 96 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2020 – 2022
Study locations (1)
- Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
Collaborators
Shenzhen Second People's Hospital · The Seventh Affiliated Hospital of Sun Yat-sen University · Maoming People's Hospital · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Shenzhen Hospital, Southern Medical University · Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine · The First People's Hospital of Chenzhou · Peking University Shenzhen Hospital · Zhongshan People's Hospital, Guangdong, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04424147 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.